Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
616.00    -8.00 (-1.28%)
Bid:
615.00
Ask:
620.00
Spread: 5.00 (0.813%)
Market Cap: £536.69m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

9 Feb 2010 07:00

RNS Number : 8437G
Victrex PLC
09 February 2010
 



 

 9 February 2010

Victrex plc

 

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2009 to date:

 

"We are pleased to report that Group sales volume for the four months to the end of January amounted to approximately 714 tonnes consolidating the positive trend in volumes in our Victrex Polymer Solutions ('VPS') business that we indicated in our preliminary results announcement in December. As expected, December sales volumes were lower than the average for the first two months of the financial year, reflecting the normal seasonal trend. However, January sales volumes rebounded and showed further growth over October and November as customers recommenced activity in the New Year. While it remains too early to predict the outcome for the year as a whole, the underlying trends being experienced across VPS are encouraging.

 

Invibio®, our biomaterials business, continues to make good progress following reduced revenue in the second half of last year caused principally by inventory rationalisation. Revenues for the four months to the end of January were at similar levels to the average run rate we achieved in 2009 (annual sales revenue of £34.2m). We remain confident that Invibio revenue for 2010 will show continued growth.

 

The Group remains in a strong financial position with a healthy balance sheet and good cash generation and there have been no significant changes in the financial position of the Company since 30 September 2009."

 

The Company's trading update for the six months to 31 March 2010 will be issued on Thursday 8 April 2010.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0207 357 9477 (9 February 2010)

David Hummel, Chief Executive 01253 897700 (thereafter)

Mike Peacock, Finance Director

 

Hogarth Partnership Limited

Nick Denton / Barnaby Fry 0207 357 9477

 

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMZMGGZVRZGGZM
Date   Source Headline
19th Dec 20121:09 pmRNSDirector/PDMR Shareholding
18th Dec 20124:40 pmRNSDirector/PDMR Shareholding
18th Dec 201210:08 amRNSHolding(s) in Company
12th Dec 20124:08 pmRNSDirector/PDMR Shareholding
11th Dec 20127:00 amRNSFinal Results
3rd Dec 20122:23 pmRNSBlocklisting Interim Review
30th Nov 20122:05 pmRNSTotal Voting Rights
20th Nov 201212:18 pmRNSDirector/PDMR Shareholding
1st Nov 201210:34 amRNSTotal Voting Rights
30th Oct 201210:28 amRNSHolding(s) in Company
18th Oct 20124:07 pmRNSDirector/PDMR Shareholding
16th Oct 201212:03 pmRNSHolding(s) in Company
16th Oct 20127:00 amRNSSite Visit
10th Oct 201210:33 amRNSHolding(s) in Company
4th Oct 20127:00 amRNSTrading Statement
28th Sep 20121:36 pmRNSTotal Voting Rights
28th Sep 20121:21 pmRNSHolding(s) in Company
19th Sep 201212:57 pmRNSDirector/PDMR Shareholding
31st Aug 20122:05 pmRNSTotal Voting Rights
20th Aug 201211:22 amRNSDirector/PDMR Shareholding
31st Jul 201212:19 pmRNSTotal Voting Rights
26th Jul 20127:00 amRNSInterim Management Statement
17th Jul 20123:35 pmRNSDirector/PDMR Shareholding
12th Jul 201210:41 amRNSHolding(s) in Company
29th Jun 20122:25 pmRNSTotal Voting Rights
27th Jun 20123:48 pmRNSDirector/PDMR Shareholding
20th Jun 20123:10 pmRNSDirector/PDMR Shareholding
14th Jun 20121:23 pmRNSDirector/PDMR Shareholding
1st Jun 201211:44 amRNSBlocklisting Interim Review
31st May 20122:55 pmRNSTotal Voting Rights
22nd May 20127:00 amRNSHalf Yearly Report
17th May 20123:52 pmRNSDirector/PDMR Shareholding
30th Apr 20124:26 pmRNSTotal Voting Rights
27th Apr 20127:00 amRNSManagement Change
26th Apr 20128:30 amRNSAdditional Listing
18th Apr 20124:10 pmRNSDirector/PDMR Shareholding
5th Apr 20127:00 amRNSTrading Update
30th Mar 201212:11 pmRNSTotal Voting Rights
26th Mar 201211:45 amRNSHolding(s) in Company
19th Mar 20123:06 pmRNSDirector/PDMR Shareholding
19th Mar 20127:00 amRNSManagement Change
29th Feb 20122:11 pmRNSTotal Voting Rights
20th Feb 201211:52 amRNSDirector/PDMR Shareholding
17th Feb 201210:39 amRNSHolding(s) in Company
13th Feb 201211:37 amRNSHolding(s) in Company
9th Feb 20123:25 pmRNSHolding(s) in Company
8th Feb 201210:33 amRNSResult of AGM
7th Feb 20127:00 amRNSAGM and Interim Management Statement
31st Jan 20123:02 pmRNSTotal Voting Rights
17th Jan 20123:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.